Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 07, 2021
Catalent, a global leader in clinical supply services, today announced the opening of its new clinical supply facility, strategically located in the Shiga prefecture of Japan, in response to increased demand for end-to-end services, including primary...
read more
Catalent welcomed the announcement by Biohaven the FDA has approved its NURTEC™ ODT for acute migraine in adults.
read more
Tuesday, December 10, 2019
Catalent has completed clinical production of Bridge Therapeutics’ opioid addiction development therapeutic product, BT-219.
read more
Humanigen has dosed the first COVID-19 patient in its study for lenzilumab, the company’s GM-CSF monoclonal antibody.
read more
Catalent has signed an agreement with Spicona to develop a virus-like protein (VLP)-based vaccine against COVID-19.
read more
Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, and Adamas Pharmaceuticals Inc., today announced an agreement for Phase 3 clinical trials ...
read more
Thursday, February 16, 2012
Catalent Pharma Solutions, a leading global drug delivery technology company, and NewMarket Pharmaceuticals LLC have entered into an agreement to jointly formulate and develop a portfolio of products for treating production and companion animals ...
read more
Catalent Pharma Solutions, a leading global drug delivery technology and advanced supply solutions company, has announced a major expansion of its controlled release drug manufacturing facility in Winchester, Kentucky. The company is to invest nearly...
read more
Tuesday, September 24, 2013
Representatives from the White House, U.S. Military, Departments of Labor and Veterans Affairs, Catalent, and Partnering Blackstone Portfolio Companies Meet to Advance Hiring of Veterans
read more
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it will commence the first phase of a ...
read more
Catalent Pharma Solutions welcomed Lexicon Pharmaceuticals’ announcement that Xermelo, has been approved by the U.S. Food and Drug Administration (FDA).
read more
Thursday, October 29, 2015
Catalent Pharma Solutions has announced that it is to quadruple cold chain capacity at its existing clinical supply storage and distribution facility in Shanghai, China.
read more
Tuesday, February 19, 2019
Catalent Pharma Solutions has received The Procter & Gamble Company’s (P&G) highest external business partner recognition, the External Business Partner of the Year Award.
read more
Wednesday, November 09, 2016
Catalent a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has announced financial results for the first quarter of fiscal year 2017, which ended September 30, 2016.
read more
Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has announced financial results for the fourth quarter and fiscal year 2016, which ended June 30, 2016.
read more